Syncom Formulations (India) informs about newspaper publication

Syncom Formulations (India) Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524470 | NSE: SYNCOMF

04 Nov 2019 Evaluate

Syncom Formulations (India) has informed about publishing of intimation of notice of 3/2019-20 Board Meeting of the company scheduled to be held on Thursday, 14th November 2019 at 4.00 pm at the Corporate Office of the Company pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(a) of SEBI (LODR) Regulations, 2015. The Company enclosed the newspaper advertisement published on 03.11.2019 in Free Press Journal English Newspaper and Marathi (vernacular) Newspaper.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1835.50
Dr. Reddys Labs.	1171.10
Cipla	1371.45
Lupin	2144.70
Zydus Lifesciences	1153.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.